Transcription of Pharmaceutical Compliance Program Elements
{{id}} {{{paragraph}}}
Pharmaceutical Compliance Program ElementsPharmaceutical Compliance ForumSeptember 15, 2009 Bridgewater, NJJohn T. BentivoglioSkadden, ArpsMatthew D AmbrosioProstrakan, of Discussion sentencing guidelines HHS OIG Guidance DOJ Guidance on Compliance programs Advanced Pharma Compliance Issues DiscussionA Brief History of Corporate Federal sentencing Guidelines1996 CaremarkDecision2001 Enron Collapse &TAP Settlement2002 PhRMACode&SOX2004 Amended SentencingGuidelines1997 OIGM odel ComplianceGuidelines(Clinical Labs)2003 OIGP harmaGuidelines&DOJ sThompsonMemoCompliance Time Line2005 Corporate sentencing guidelines provide reduction in fines for effective Compliance programs . Seven Elements a cause of action against board members for failing to take minimal steps to achieve legal Compliance now known as a Caremark Claim.
2 Topics of Discussion • U.S. Sentencing Guidelines • HHS OIG Guidance • DOJ Guidance on Compliance Programs • Advanced Pharma Compliance Issues • Discussion
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}